Healthcare entity
regulation is the sole category represented across all 1 tracked stories. Avalere Health is most often covered alongside Amgen, which appears in 1 of these 1 story. They are better corroborated than the beat average, carrying 4 original sources each against 2.2 for the same window.
Last mentioned: Jul 27, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
regulation is the sole category represented across all 1 tracked stories. Avalere Health is most often covered alongside Amgen, which appears in 1 of these 1 story. They are better corroborated than the beat average, carrying 4 original sources each against 2.2 for the same window. At 5, the average consequence score sits below the same-window beat average of 6. Avalere Health appears in 1 tracked Healthcare story from July 27, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 23 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Avalere Health. Shared-story counts are live from our verified record — not editorial picks.
Copay accumulator programs are shifting thousands in drug costs back to patients, causing financial distress and potential treatment delays. Larry Gruber’s experience with Oscar Health highlights the human toll of insurance practices that prioritize cost over care.
Avalere Health is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
